Le Lézard1d
Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
Arrowhead Pharmaceuticals, Inc. today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran. These ...
Le Lézard1d
Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals, Inc. today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for investigational plozasiran for the treatment of ...
Business Insider1d
Arrowhead announces new PALISADE study results
In the OLE, a total of 418 subjects from the Phase 2 MUIR study in patients with mixed hyperlipidemia and the SHASTA-2 study in patients with severe hypertriglyceridemia entered the extension in which ...
Johns Hopkins Newsletter5d
Amber Salter speaks on comorbidities and outcomes in multiple sclerosis research
On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...
Frontiers29d
Association between tea consumption and stroke in the American adult females: analyses of NHANES 2011–2018 data
Ultimately, we also demonstrated that people who drink sugar free tea have a lower risk of stroke, and even after adjusting for mixed factors ... hypertension and hyperlipidemia. We conducted this ...
Medscape6d
Hyperlipidemia in Racial/Ethnic Minorities: Differences in Lipid Profiles and the Impact of Statin Therapy
Hyperlipidemia is a powerful and extremely common risk factor for cardiovascular disease (CVD) among all racial/ethnic groups. However, there are certain racial/ethnic differences in the ...
Medscape7d
Reduction of Cholesterol and Other Cardiovascular Disease Risk Factors by Alternative Therapies
A number of preliminary clinical trials have demonstrated the efficacy of functional foods for the treatment of hyperlipidemia and hyperglycemia. Reductions in the levels of total cholesterol ...
Frontiers7d
A review on the treatment of hyperlipidemia with Erchen Decoction
Hyperlipidemia, commonly referred to as dyslipidemia, is characterized by elevated serum cholesterol and/or triglyceride levels. This condition contributes significantly to the high mortality rates ...
Healthline28d
Side Effects of Leqvio: What You Need to Know
Specifically, Leqvio is used to reduce low-density lipoprotein (LDL) cholesterol* in adults with primary hyperlipidemia (a level of fats in the blood, such as cholesterol). This can include adults ...